Panacea Biotec Email Format
Pharmaceutical ManufacturingDelhi, India1001-5000 Employees
Panacea Biotec is a research-based health management company engaged in the development, manufacturing, and marketing of pharmaceutical medicines, vaccines, and herbal products. Its portfolio spans high-value prescription therapies across pain management, diabetes, cardiovascular and renal disease, osteoporosis, and gastrointestinal care, alongside a broad vaccine program. The company's vaccine initiatives include fully liquid versions of hexavalent and pentavalent vaccines, various oral polio vaccines, and an emerging pipeline that covers pneumococcal conjugate and dengue vaccines. It has supported large-scale immunization efforts and maintains partnerships with international health bodies such as WHO, GAVI, UNICEF, and national programs. It operates from Delhi, India, with facilities that meet WHO prequalification and US FDA standards and adhere to cGMP requirements, and its products reach more than 145 countries, including the United States and Germany. A recent development includes UNICEF awarding a contract for the supply of bOPV vaccines.